Rhone, P.; Bielawski, K.; Ziołkowska, K.; Rość, D.; Ruszkowska-Ciastek, B.
Low Pre-Treatment Count of Circulating Endothelial Progenitors as a Prognostic Biomarker of the High Risk of Breast Cancer Recurrence. J. Clin. Med. 2019, 8, 1984.
https://doi.org/10.3390/jcm8111984
AMA Style
Rhone P, Bielawski K, Ziołkowska K, Rość D, Ruszkowska-Ciastek B.
Low Pre-Treatment Count of Circulating Endothelial Progenitors as a Prognostic Biomarker of the High Risk of Breast Cancer Recurrence. Journal of Clinical Medicine. 2019; 8(11):1984.
https://doi.org/10.3390/jcm8111984
Chicago/Turabian Style
Rhone, Piotr, Kornel Bielawski, Katarzyna Ziołkowska, Danuta Rość, and Barbara Ruszkowska-Ciastek.
2019. "Low Pre-Treatment Count of Circulating Endothelial Progenitors as a Prognostic Biomarker of the High Risk of Breast Cancer Recurrence" Journal of Clinical Medicine 8, no. 11: 1984.
https://doi.org/10.3390/jcm8111984
APA Style
Rhone, P., Bielawski, K., Ziołkowska, K., Rość, D., & Ruszkowska-Ciastek, B.
(2019). Low Pre-Treatment Count of Circulating Endothelial Progenitors as a Prognostic Biomarker of the High Risk of Breast Cancer Recurrence. Journal of Clinical Medicine, 8(11), 1984.
https://doi.org/10.3390/jcm8111984